Announced Tue, 26 May · 13:22 IST

Dear Sir, Submitting herewith the Disclosure 29(1) as required under SEBI (SAST) Regulations, 2011 submitted by Mr Padam Dugar the acquirer . Kindly take the same on records. For ....

Creeping Acquisition Near ThresholdOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹46.20
prior close
₹48.51
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+10.2+15.7+21.5+27.6+33.9+33.7+26.1+71.7+78.7
Up moveDown movePending
AI summary

Colinz Laboratories Ltd received disclosure under SEBI SAST Regulations regarding off-market acquisition of equity shares on May 21, 2026. Mr. Padam Dugar acquired 3,16,000 shares (12.54%), while three Persons Acting in Concert (Annjana Dugar, Likhitta Dugar, and Antariksh Dugar) acquired additional shares totalling 62,000 (2.47%). The acquirer group collectively purchased 3,78,000 shares representing 15.01% of the company's total share capital of Rs. 2,51,91,000 (25,19,100 shares of Rs. 10 each). Prior to this acquisition, all acquirers held zero shares. The acquirer and PACs have explicitly stated they do not belong to the Promoter/Promoter group.

Likely market impact

An outsider acquiring 15.01% stake in a single off-market transaction is a significant development. This represents creeping acquisition as the group crosses into substantial shareholding territory, bringing them closer to the 25% threshold that would trigger mandatory open offer requirements under SEBI regulations.